Filing Details

Accession Number:
0000950170-24-074473
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-17 18:45:28
Reporting Period:
2024-06-14
Accepted Time:
2024-06-17 18:45:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1111485 Rxsight Inc. RXST Ophthalmic Goods (3851) 943268801
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550508 Julie Andrews C/O Rxsight, Inc.
100 Columbia
Aliso Viejo CA 92656
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-14 11,940 $57.84 33,972 No 4 S Direct
Common Stock Disposition 2024-06-14 3,685 $58.53 30,287 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2024 by the Reporting Person.
  2. Represents the weighted average share price of an aggregate total of 11,940 shares sold in the price range of $57.32 to $58.29 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 3,685 shares sold in the price range of $58.32 to $59.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.